Skip to content
Request Info
+61 2 9209 4035
  • Home
  • Solutions
    • Patient Data Analytics
    • Longitudinal Patient Data
    • Data Mapping
    • Pharma Data Analytics & Software
    • Pharma Intelligence & Business Intelligence
    • Data Science
    • Geospatial Mapping
  • Products
    • Platform
    • Market Insights
    • Patient Insights
    • Patient Journey
    • Provider Insights
    • Cohort Builder
    • Patient Profiler
    • Triggers
    • Services
    • Subpopulation Insights
    • RWE Publication
    • Clinical Decision Support
    • Market Assessment
  • About
    • About Prospection
    • Work With Us
  • Articles
  • Contact
  • English
  • Home
  • Solutions
    • Patient Data Analytics
    • Longitudinal Patient Data
    • Data Mapping
    • Pharma Data Analytics & Software
    • Pharma Intelligence & Business Intelligence
    • Data Science
    • Geospatial Mapping
  • Products
    • Platform
    • Market Insights
    • Patient Insights
    • Patient Journey
    • Provider Insights
    • Cohort Builder
    • Patient Profiler
    • Triggers
    • Services
    • Subpopulation Insights
    • RWE Publication
    • Clinical Decision Support
    • Market Assessment
  • About
    • About Prospection
    • Work With Us
  • Articles
  • Contact
  • English

Day: October 17, 2020

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)

Introduction: To describe the persistence of treatment with subcutaneous tumor necrosis factor inhibitors (TNFi) adalimumab, etanercept, and golimumab in immune-mediated rheumatic dis-
ease (rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis) by treatment sequence (first-line treatment, second-line or further lines of treatment).

Prospection is a leading provider of actionable real world evidence

  • Patient Data Analytics
  • Pharma Intelligence Asia-Pacific
  • Longitudinal Patient Data
  • Pharma Intelligence Japan
  • Data Mapping
  • Pharma Intelligence Singapore
  • Pharma Data Analytics & Software
  • Pharma Intelligence USA
  • Pharma Intelligence & Business Intelligence
  • Pharma Intelligence United Kingdom
  • Data Science
  • Geospatial Mapping
  • Patient Data Analytics
  • Pharma Intelligence Asia-Pacific
  • Longitudinal Patient Data
  • Pharma Intelligence Japan
  • Data Mapping
  • Pharma Intelligence Singapore
  • Pharma Data Analytics & Software
  • Pharma Intelligence USA
  • Pharma Intelligence & Business Intelligence
  • Pharma Intelligence United Kingdom
  • Data Science
  • Geospatial Mapping

Contact Us

  • Level 6 Sydney Central
    477 Pitt Street Haymarket
    NSW 2000 Australia
  • +61 2 9209 4035
  • prospection@prospection.com
Twitter Linkedin

Stay Updated

Register here to stay informed about Prospection

Copyright 2021 Prospection | All Rights Reserved
Privacy Policy
Request Info
+61 2 9209 4035
  • Home
  • Solutions
    • Patient Data Analytics
    • Longitudinal Patient Data
    • Data Mapping
    • Pharma Data Analytics & Software
    • Pharma Intelligence & Business Intelligence
    • Data Science
    • Geospatial Mapping
  • Products
    • Platform
    • Market Insights
    • Patient Insights
    • Patient Journey
    • Provider Insights
    • Cohort Builder
    • Patient Profiler
    • Triggers
    • Services
    • Subpopulation Insights
    • RWE Publication
    • Clinical Decision Support
    • Market Assessment
  • About
    • About Prospection
    • Work With Us
  • Articles
  • Contact
  • English
Request Demo
Login
  • English